2023
DOI: 10.1016/s1473-3099(22)00528-x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 26 publications
0
4
0
1
Order By: Relevance
“…10 The results of several randomized controlled trials (RCTs) support the use of shorter antibiotic durations in comparison to traditional courses in a variety of infections, 11 with a recent study showing non-inferiority in treating Lyme disease with 7 days of doxycycline compared with 14 days. 12 Furthermore, the benefits of a shorter antibiotic course extend beyond preserving future antibiotic efficacy, including cost-efficiency, convenience, potentially encouraging better adherence, and protecting individuals from harm caused by unnecessary antibiotics.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…10 The results of several randomized controlled trials (RCTs) support the use of shorter antibiotic durations in comparison to traditional courses in a variety of infections, 11 with a recent study showing non-inferiority in treating Lyme disease with 7 days of doxycycline compared with 14 days. 12 Furthermore, the benefits of a shorter antibiotic course extend beyond preserving future antibiotic efficacy, including cost-efficiency, convenience, potentially encouraging better adherence, and protecting individuals from harm caused by unnecessary antibiotics.…”
Section: Discussionmentioning
confidence: 99%
“…In an era where STI rates continue to rise and evolving antimicrobial resistance is threatening effective management of infections globally, it is vital for clinicians to review treatment guidelines to rationalize antibiotic use and recommend the shortest effective antibiotic course possible 10 . The results of several randomized controlled trials (RCTs) support the use of shorter antibiotic durations in comparison to traditional courses in a variety of infections, 11 with a recent study showing non-inferiority in treating Lyme disease with 7 days of doxycycline compared with 14 days 12 . Furthermore, the benefits of a shorter antibiotic course extend beyond preserving future antibiotic efficacy, including cost-efficiency, convenience, potentially encouraging better adherence, and protecting individuals from harm caused by unnecessary antibiotics.…”
Section: Discussionmentioning
confidence: 99%
“…In patients with myalgia, headache, and persistent fatigue after a tick bite, infection with SFG rickettsiae should be suspected, tested, and possibly treated, unless they have already received adequate therapy. In patients with early Lyme disease, in whom antibody testing for SFG rickettsiae and A. phagocytophilum was not performed, tetracyline (specifically doxycycline) should be considered as first-line therapy after a tick bite to treat possible infection with SFG rickettsiae and A. phagocyophilum [ [32] , [33] , [34] ].…”
Section: Discussionmentioning
confidence: 99%
“…Selbst beim Auftreten von multiplen EM ist eine 14tägige orale Doxycyclintherapie einer i. v.-Antibiose gleichwertig [29]. Bei EM ist nach neueren Studiendaten eine 7-tägige Doxycyclintherapie einer 14-tägigen Applikation nicht unterlegen [30]. Daten in Bezug auf die Wirksamkeit von Penicillin bei Lyme-Arthritis sind z.T.…”
Section: Therapie Der Lyme-borrelioseunclassified